É uma doença genética que afeta o metabolismo, causada pela falta de uma enzima. Por causa disso, o corpo não consegue queimar as gorduras para produzir energia.
Introdução
O que você precisa saber de cara
A síndrome de Boucher-Neuhäuser é um distúrbio raro que afeta o movimento, a visão e o desenvolvimento sexual. Faz parte de um espectro contínuo de condições neurológicas, conhecidas como distúrbios relacionados ao PNPLA6, que compartilham uma causa genética e apresentam uma combinação de características sobrepostas. A síndrome de Boucher-Neuhäuser é caracterizada por três características específicas: ataxia, hipogonadismo hipogonadotrófico e distrofia coriorretiniana.
Ataxia descreve dificuldade de coordenação e equilíbrio. Na síndrome de Boucher-Neuhäuser, ela surge de uma perda de células (atrofia) na parte do cérebro envolvida na coordenação dos movimentos (o cerebelo). As pessoas com a condição apresentam um estilo de marcha instável e quedas frequentes.
Outra característica importante da síndrome de Boucher-Neuhäuser é o hipogonadismo hipogonadotrófico, que é uma condição que afeta a produção de hormônios que dirigem o desenvolvimento sexual. As pessoas com a condição apresentam atraso no desenvolvimento dos sinais típicos da puberdade, como o crescimento de pelos faciais e o aprofundamento da voz em homens, e o início da menstruação (períodos mensais) e o desenvolvimento das mamas em mulheres. Outras anomalias hormonais levam a baixa estatura em algumas pessoas com a condição.
A terceira característica da síndrome de Boucher-Neuhäuser são as anomalias oculares, mais comumente a distrofia coriorretiniana. Distrofia coriorretiniana refere-se a problemas com o tecido sensível à luz que reveste a parte posterior do olho (a retina) e uma camada de tecido adjacente chamada coróide. Essas anomalias oculares levam a visão comprometida. Pessoas com a síndrome de Boucher-Neuhäuser também podem apresentar movimentos oculares anormais, incluindo movimentos involuntários de oscilação lateral dos olhos (nistagmo).
As características principais da síndrome de Boucher-Neuhäuser podem começar a qualquer momento, desde a infância até a idade adulta, embora pelo menos uma característica geralmente apareça até a adolescência. A ataxia costuma ser o sintoma inicial do distúrbio, mas problemas de visão ou puberdade atrasada podem ser o achado mais precoce. Os problemas de visão e de movimento pioram lentamente ao longo da vida e podem resultar em cegueira ou na necessidade de cadeira de rodas para mobilidade nas pessoas mais gravemente afetadas.
Pessoas com a síndrome de Boucher-Neuhäuser podem apresentar problemas médicos adicionais, incluindo rigidez muscular (espasticidade); fala comprometida (disartria); e dificuldade de processar, aprender ou lembrar informações (comprometimento cognitivo).
Fonte: MedlinePlus Genetics (NLM/NIH), traduzidoÉ uma doença genética que afeta o metabolismo, causada pela falta de uma enzima. Por causa disso, o corpo não consegue queimar as gorduras para produzir energia.
O que está sendo pesquisado
Encontrou um erro ou informação desatualizada? Sugira uma correção →
Entender a doença
Do básico ao detalhe, leia no seu ritmo
Preparando trilha educativa...
Sinais e sintomas
O que aparece no corpo e com que frequência cada sintoma acontece
Partes do corpo afetadas
+ 1050 sintomas em outras categorias
Características mais comuns
Os sintomas variam de pessoa para pessoa. Abaixo estão as 2299 características clínicas mais associadas, ordenadas por frequência.
Linha do tempo da pesquisa
Encontrou um erro ou informação desatualizada? Sugira uma correção →
Genética e causas
O que está alterado no DNA e como passa nas famílias
Genes associados
75 genes identificados com associação a esta condição.
Hyperlipoproteinemia 3
A disorder characterized by the accumulation of intermediate-density lipoprotein particles (IDL or broad-beta-lipoprotein) rich in cholesterol. Clinical features include xanthomas, yellowish lipid deposits in the palmar crease, or less specific on tendons and on elbows. The disorder rarely manifests before the third decade in men. In women, it is usually expressed only after the menopause.
Multiple mitochondrial dysfunctions syndrome 3
A severe disorder of systemic energy metabolism, resulting in weakness, respiratory failure, lack of neurologic development, lactic acidosis, hyperglycinemia and early death. Some patients show failure to thrive, pulmonary hypertension, hypotonia and irritability. Biochemical features include severe combined deficiency of the 2-oxoacid dehydrogenases, defective lipoic acid synthesis and reduction in activity of mitochondrial respiratory chain complexes.
Krabbe disease
An autosomal recessive disorder characterized by insufficient catabolism of several galactolipids that are important for normal myelin production. Four clinical forms are recognized. The infantile form accounts for 90% of cases. It manifests before six months of age with irritability, spasticity, arrest of motor and mental development, and bouts of temperature elevation without infection. This is followed by myoclonic jerks of arms and legs, oposthotonus, hypertonic fits, and mental regression, which progresses to a severe decerebrate condition with no voluntary movements and death from respiratory infections or cerebral hyperpyrexia before 2 years of age. Cases with later onset present with unexplained blindness, weakness and sensorimotor peripheral neuropathy, mental deterioration and death.
Lipoid proteinosis
Rare autosomal recessive disorder characterized by generalized thickening of skin, mucosae and certain viscera. Classical features include beaded eyelid papules and laryngeal infiltration leading to hoarseness. Histologically, there is widespread deposition of hyaline material and disruption/reduplication of basement membrane.
Niemann-Pick disease C2
A lysosomal storage disorder that affects the viscera and the central nervous system. It is due to defective intracellular processing and transport of low-density lipoprotein derived cholesterol. It causes accumulation of cholesterol in lysosomes, with delayed induction of cholesterol homeostatic reactions. Niemann-Pick disease type C2 has a highly variable clinical phenotype. Clinical features include variable hepatosplenomegaly and severe progressive neurological dysfunction such as ataxia, dystonia and dementia. The age of onset can vary from infancy to late adulthood.
GM1-gangliosidosis 1
An autosomal recessive lysosomal storage disease marked by the accumulation of GM1 gangliosides, glycoproteins and keratan sulfate primarily in neurons of the central nervous system. GM1-gangliosidosis type 1 is characterized by onset within the first three months of life, central nervous system degeneration, coarse facial features, hepatosplenomegaly, skeletal dysmorphology reminiscent of Hurler syndrome, and rapidly progressive psychomotor deterioration. Urinary oligosaccharide levels are high. It leads to death usually between the first and second year of life.
Mevalonic aciduria
Accumulation of mevalonic acid which causes a variety of symptoms such as psychomotor retardation, dysmorphic features, cataracts, hepatosplenomegaly, lymphadenopathy, anemia, hypotonia, myopathy, and ataxia.
Glutaric aciduria 2C
An autosomal recessively inherited disorder of fatty acid, amino acid, and choline metabolism. It is characterized by multiple acyl-CoA dehydrogenase deficiencies resulting in large excretion not only of glutaric acid, but also of lactic, ethylmalonic, butyric, isobutyric, 2-methyl-butyric, and isovaleric acids.
Auditory neuropathy and optic atrophy
An autosomal recessive disease characterized by hearing loss, visual impairment and optic atrophy, with onset in the first or second decades of life. Optic atrophy is caused by degeneration of nerve fibers which arise in the retina and converge to form the optic disk, optic nerve, optic chiasm and optic tracts.
Pelger-Huet anomaly
An autosomal dominant inherited abnormality of granulocytes, characterized by abnormal ovoid shape, reduced nuclear segmentation and an apparently looser chromatin structure.
Hypercholanemia, familial, 1
A disorder characterized by elevated serum bile acid concentrations, itching, and fat malabsorption.
Hyperphosphatasia with impaired intellectual development syndrome 4
An autosomal recessive neurologic disorder characterized by profound developmental delay, severe intellectual disability, no speech, psychomotor delay, postnatal microcephaly, and elevated serum alkaline phosphatase.
Hyperlipoproteinemia 1
An autosomal recessive metabolic disorder characterized by defective breakdown of dietary fats, impaired clearance of chylomicrons from plasma causing the plasma to have a milky appearance, and severe hypertriglyceridemia. On a normal diet, patients often present with abdominal pain, hepatosplenomegaly, lipemia retinalis, eruptive xanthomata, and massive hypertriglyceridemia, sometimes complicated with acute pancreatitis.
Abetalipoproteinemia
An autosomal recessive disorder of lipoprotein metabolism. Affected individuals produce virtually no circulating apolipoprotein B-containing lipoproteins (chylomicrons, VLDL, LDL, lipoprotein(A)). Malabsorption of the antioxidant vitamin E occurs, leading to spinocerebellar and retinal degeneration.
Peroxisome biogenesis disorder 2A
A fatal peroxisome biogenesis disorder belonging to the Zellweger disease spectrum and characterized clinically by severe neurologic dysfunction with profound psychomotor retardation, severe hypotonia and neonatal seizures, craniofacial abnormalities, liver dysfunction, and biochemically by the absence of peroxisomes. Additional features include cardiovascular and skeletal defects, renal cysts, ocular abnormalities, and hearing impairment. Most severely affected individuals with the classic form of the disease (classic Zellweger syndrome) die within the first year of life.
Hypercholesterolemia, familial, 4
A form of hypercholesterolemia, a disorder of lipoprotein metabolism characterized by elevated serum low-density lipoprotein (LDL) cholesterol levels, which result in excess deposition of cholesterol in tissues and leads to xanthelasma, xanthomas, accelerated atherosclerosis and increased risk of premature coronary heart disease. FHCL4 inheritance is autosomal recessive.
Pseudovaginal perineoscrotal hypospadias
A form of male pseudohermaphroditism in which 46,XY males show ambiguous genitalia at birth, including perineal hypospadias and a blind perineal pouch, and develop masculinization at puberty. The name of the disorder stems from the finding of a blind-ending perineal opening resembling a vagina and a severely hypospadiac penis with the urethra opening onto the perineum.
Spastic paraplegia 5A, autosomal recessive
A form of spastic paraplegia, a neurodegenerative disorder characterized by a slow, gradual, progressive weakness and spasticity of the lower limbs. Rate of progression and the severity of symptoms are quite variable. Initial symptoms may include difficulty with balance, weakness and stiffness in the legs, muscle spasms, and dragging the toes when walking. In some forms of the disorder, bladder symptoms (such as incontinence) may appear, or the weakness and stiffness may spread to other parts of the body.
GM2-gangliosidosis 1
An autosomal recessive lysosomal storage disease marked by the accumulation of GM2 gangliosides in the neuronal cells. It is characterized by GM2 gangliosides accumulation in the absence of HEXA activity, leading to neurodegeneration and, in the infantile form, death in early childhood. It exists in several forms: infantile (most common and most severe), juvenile and adult (late-onset).
Glutaric aciduria 2B
An autosomal recessively inherited disorder of fatty acid, amino acid, and choline metabolism. It is characterized by multiple acyl-CoA dehydrogenase deficiencies resulting in large excretion not only of glutaric acid, but also of lactic, ethylmalonic, butyric, isobutyric, 2-methyl-butyric, and isovaleric acids.
Hepatic lipase deficiency
A disorder characterized by elevated levels of beta-migrating very low density lipoproteins, and abnormally triglyceride-rich low and high density lipoproteins.
Lipoyltransferase 1 deficiency
An autosomal recessive disorder due to a defect in lipoic acid metabolism, resulting in severe lactic acidosis and metabolic decompensation. Variable clinical manifestations include delayed psychomotor development, severe hypotonia, dystonia, loss of head control, coma, bradycardia, and pulmonary hypertension.
Hypercholesterolemia, familial, 1
A form of hypercholesterolemia, a disorder of lipoprotein metabolism characterized by elevated serum low-density lipoprotein (LDL) cholesterol levels, which result in excess deposition of cholesterol in tissues and leads to xanthelasma, xanthomas, accelerated atherosclerosis and increased risk of premature coronary heart disease. FHCL1 inheritance is autosomal dominant.
Lathosterolosis
An autosomal recessive disorder characterized by multiple congenital anomalies affecting axial and appendicular skeleton, liver, central nervous and urogenital systems, and lysosomal storage.
Epilepsy, progressive myoclonic 4, with or without renal failure
A form of progressive myoclonic epilepsy, a clinically and genetically heterogeneous group of disorders defined by the combination of action and reflex myoclonus, other types of epileptic seizures, and progressive neurodegeneration and neurocognitive impairment. EPM4 is an autosomal recessive form associated with renal failure in some cases. Cognitive function is preserved.
Gaucher disease
An autosomal recessive lysosomal storage disease due to deficient activity of lysosomal beta-glucocerebrosidase, and characterized by accumulation of glucosylceramide in the reticulo-endothelial system. GD is a multisystem disease historically divided into three main subtypes on the basis of the presence of neurologic involvement, age at onset and progression rate: type 1 is the non-neuropathic form, type 2 is the acute neuropathic form with early onset and rapid neurologic deterioration, type 3 is the chronic neuropathic form with slow progression of neurologic features. GD shows a marked phenotypic diversity ranging from adult asymptomatic forms, at the mild end, to perinatal lethal forms at the severe end of the disease spectrum. Formal diagnosis of Gaucher disease is based on the measurement of glucocerebrosidase levels in circulating leukocytes and molecular genetic analysis.
Neurodevelopmental disorder with hypotonia and cerebellar atrophy, with or without seizures
An autosomal recessive neurodevelopmental disorder characterized by global developmental delay, intellectual disability, hypotonia, cerebellar ataxia, cerebellar atrophy, delayed motor skills, poor or absent speech, and epilepsy in most patients. Some patients manifest facial dysmorphism. Disease onset is in infancy.
Multiple mitochondrial dysfunctions syndrome 6
An autosomal recessive, neurodegenerative disorder characterized by basal ganglia lesions, cerebellar atrophy, and neurologic regression in the first year of life. Common features include truncal hypotonia, lack of independent ambulation, poor speech, intellectual disability, and motor abnormalities, such as ataxia, dystonia, and spasticity.
Multiple congenital anomalies-hypotonia-seizures syndrome 3
An autosomal recessive syndrome characterized by distinct facial features, intellectual disability, hypotonia and seizures, in combination with abnormal skeletal, endocrine, and ophthalmologic findings including impaired vision, as well as abnormal motility of the eyes.
Cholesteryl ester storage disease
An autosomal recessive, mild form of lysosomal acid lipase deficiency characterized by accumulation of cholesteryl esters and triglycerides primarily in the liver. The clinical presentation is highly variable depending on residual levels of lysosomal acid lipase activity, and ranges from early onset of severe cirrhosis to later onset of more slowly progressive hepatic disease with survival into adulthood. Age at onset varies from childhood to adulthood.
Microcephaly, congenital cataract, and psoriasiform dermatitis
An autosomal recessive inborn error of cholesterol metabolism characterized by accumulation of a large amount of methylsterols, particularly dimethylsterols, in affected individuals. Patients manifest psoriasiform dermatitis, arthralgias, congenital cataracts, microcephaly, and developmental delay.
Multiple mitochondrial dysfunctions syndrome 4
A severe disorder of systemic energy metabolism, resulting in weakness, respiratory failure, lack of neurologic development, lactic acidosis, hyperglycinemia and early death.
Hypercholanemia, familial, 2
An autosomal recessive inborn error of metabolism characterized by persistently increased plasma levels of conjugated bile salts apparent from infancy, fat malabsorption and impaired absorption of fat-soluble vitamins, including D and K. Most patients are asymptomatic. Some neonates may have transient jaundice or transiently elevated liver enzymes.
Lecithin-cholesterol acyltransferase deficiency
A disorder of lipoprotein metabolism characterized by inadequate esterification of plasmatic cholesterol. Two clinical forms are recognized: complete LCAT deficiency and fish-eye disease. LCATD is generally referred to the complete form which is associated with absence of both alpha and beta LCAT activities resulting in esterification anomalies involving both HDL (alpha-LCAT activity) and LDL (beta-LCAT activity). It causes a typical triad of diffuse corneal opacities, target cell hemolytic anemia, and proteinuria with renal failure.
Mitochondrial trifunctional protein deficiency 1
An autosomal recessive metabolic disorder of long-chain fatty acid oxidation, biochemically characterized by loss of all enzyme activities of the mitochondrial trifunctional protein complex. The disease phenotype ranges from a fatal form characterized by early-onset cardiomyopathy, cardiac failure and early death to less severe, late-onset forms with myopathy, recurrent rhabdomyolysis, and sensorimotor axonal neuropathy as key features.
Coloboma, congenital heart disease, ichthyosiform dermatosis, impaired intellectual development, and ear anomalies syndrome
An extremely rare autosomal recessive multisystem disorder clinically characterized by colobomas, congenital heart defects, migratory ichthyosiform dermatosis, intellectual disability, and ear anomalies including conductive hearing loss. Other clinical features include distinctive facial features, abnormal growth, genitourinary abnormalities, seizures, and feeding difficulties.
Smith-Lemli-Opitz syndrome
An autosomal recessive frequent inborn disorder of sterol metabolism with characteristic congenital malformations and intellectual disability. Children with SLOS have elevated serum 7-dehydrocholesterol (7-DHC) levels and low serum cholesterol levels. SLOS occurs in relatively high frequency: approximately 1 in 20,000 to 30,000 births in populations of northern and central European background. Historically, a clinical distinction often was made between classic ('type I') SLOS and the more severely affected ('type II') patients. There is, in reality, a clinical and biochemical continuum from mild to severe SLOS.
2,4-dienoyl-CoA reductase deficiency
A rare, autosomal recessive, inborn error of polyunsaturated fatty acids and lysine metabolism, resulting in mitochondrial dysfunction. Affected individuals have a severe encephalopathy with neurologic and metabolic abnormalities beginning in early infancy. Laboratory studies show increased C10:2 carnitine levels and hyperlysinemia.
Pfeiffer syndrome
A syndrome characterized by the association of craniosynostosis, broad and deviated thumbs and big toes, and partial syndactyly of the fingers and toes. Three subtypes are known: mild autosomal dominant form (type 1); cloverleaf skull, elbow ankylosis, early death, sporadic (type 2); craniosynostosis, early demise, sporadic (type 3).
Anemia, sideroblastic, 3, pyridoxine-refractory
A form of sideroblastic anemia, a bone marrow disorder defined by the presence of pathologic iron deposits in erythroblast mitochondria. Sideroblastic anemia is characterized by anemia of varying severity, hypochromic peripheral erythrocytes, systemic iron overload secondary to chronic ineffective erythropoiesis, and the presence of bone marrow ringed sideroblasts. Sideroblasts are characterized by iron-loaded mitochondria clustered around the nucleus. SIDBA3 is refractory to treatment with vitamin B6, while iron chelation therapy may result in clinical improvement. SIDBA3 inheritance is autosomal recessive.
Neuropathy, hereditary sensory and autonomic, 1C
A form of hereditary sensory and autonomic neuropathy, a genetically and clinically heterogeneous group of disorders characterized by degeneration of dorsal root and autonomic ganglion cells, and by prominent sensory abnormalities with a variable degree of motor and autonomic dysfunction. The neurological phenotype is often complicated by severe infections, osteomyelitis, and amputations. HSAN1C symptoms include loss of touch and vibration in the feet, dysesthesia and severe panmodal sensory loss in the upper and lower limbs, distal lower limb sensory loss with ulceration and osteomyelitis, and distal muscle weakness.
Dihydrolipoamide dehydrogenase deficiency
An autosomal recessive metabolic disorder characterized biochemically by a combined deficiency of the branched-chain alpha-keto acid dehydrogenase complex (BCKDC), pyruvate dehydrogenase complex (PDC), and alpha-ketoglutarate dehydrogenase complex (KGDC). Clinically, affected individuals have lactic acidosis and neurologic deterioration due to sensitivity of the central nervous system to defects in oxidative metabolism.
3-hydroxy-3-methylglutaryl-CoA synthase-2 deficiency
A metabolic disorder characterized by severe hypoketotic hypoglycemia, encephalopathy, and hepatomegaly.
Neurodegeneration with brain iron accumulation 1
Autosomal recessive neurodegenerative disorder associated with iron accumulation in the brain, primarily in the basal ganglia. Clinical manifestations include progressive muscle spasticity, hyperreflexia, muscle rigidity, dystonia, dysarthria, and intellectual deterioration which progresses to severe dementia over several years. It is clinically classified into classic, atypical, and intermediate phenotypes. Classic forms present with onset in first decade, rapid progression, loss of independent ambulation within 15 years. Atypical forms have onset in second decade, slow progression, maintenance of independent ambulation up to 40 years later. Intermediate forms manifest onset in first decade with slow progression or onset in second decade with rapid progression. Patients with early onset tend to also develop pigmentary retinopathy, whereas those with later onset tend to also have speech disorders and psychiatric features. All patients have the 'eye of the tiger' sign on brain MRI.
GM2-gangliosidosis 2
An autosomal recessive lysosomal storage disease marked by the accumulation of GM2 gangliosides in the neuronal cells. Clinically indistinguishable from GM2-gangliosidosis type 1, presenting startle reactions, early blindness, progressive motor and mental deterioration, macrocephaly and cherry-red spots on the macula.
Niemann-Pick disease A
An early-onset lysosomal storage disorder caused by failure to hydrolyze sphingomyelin to ceramide. It results in the accumulation of sphingomyelin and other metabolically related lipids in reticuloendothelial and other cell types throughout the body, leading to cell death. Niemann-Pick disease type A is a primarily neurodegenerative disorder characterized by onset within the first year of life, intellectual disability, digestive disorders, failure to thrive, major hepatosplenomegaly, and severe neurologic symptoms. The severe neurological disorders and pulmonary infections lead to an early death, often around the age of four. Clinical features are variable. A phenotypic continuum exists between type A (basic neurovisceral) and type B (purely visceral) forms of Niemann-Pick disease, and the intermediate types encompass a cluster of variants combining clinical features of both types A and B.
Dystonia, childhood-onset, with optic atrophy and basal ganglia abnormalities
An autosomal recessive neurologic disorder characterized by childhood-onset dystonia, basal ganglia degeneration and optic atrophy with decreased visual acuity. Dystonia is defined by the presence of sustained involuntary muscle contraction, often leading to abnormal postures. DYTOABG severity is variable, and some patients lose independent ambulation.
GM2-gangliosidosis AB
An autosomal recessive lysosomal storage disease marked by the accumulation of GM2 gangliosides in the neuronal cells. It is characterized by GM2 gangliosides accumulation in the presence of both normal hexosaminidase A and B.
Hyperphosphatasia with impaired intellectual development syndrome 6
An autosomal recessive, multisystem disorder characterized by severe developmental delay, dysmorphism, seizures, cataracts, and early death in some patients.
Epilepsy, progressive myoclonic 3, with or without intracellular inclusions
A form of progressive myoclonic epilepsy, a clinically and genetically heterogeneous group of disorders defined by the combination of action and reflex myoclonus, other types of epileptic seizures, and progressive neurodegeneration and neurocognitive impairment. EPM3 is an autosomal recessive, severe, form with early onset. Multifocal myoclonic seizures begin between 16 and 24 months of age after normal initial development. Neurodegeneration and regression occur with seizure onset. Other features include intellectual disability, dysarthria, truncal ataxia, and loss of fine finger movements. EEG shows slow dysrhythmia, multifocal and occasionally generalized epileptiform discharges. In some patients, ultrastructural findings on skin biopsies identify intracellular accumulation of autofluorescent lipopigment storage material, consistent with neuronal ceroid lipofuscinosis.
Mitochondrial trifunctional protein deficiency 2
An autosomal recessive metabolic disorder of long-chain fatty acid oxidation, biochemically characterized by loss of all enzyme activities of the mitochondrial trifunctional protein complex. The disease phenotype ranges from a fatal form characterized by early-onset cardiomyopathy, cardiac failure and early death to less severe, late-onset forms with myopathy, recurrent rhabdomyolysis, and sensorimotor axonal neuropathy as key features.
Glutaric aciduria 2A
An autosomal recessively inherited disorder of fatty acid, amino acid, and choline metabolism. It is characterized by multiple acyl-CoA dehydrogenase deficiencies resulting in large excretion not only of glutaric acid, but also of lactic, ethylmalonic, butyric, isobutyric, 2-methyl-butyric, and isovaleric acids.
Niemann-Pick disease C1
A lysosomal storage disorder that affects the viscera and the central nervous system. It is due to defective intracellular processing and transport of low-density lipoprotein derived cholesterol. It causes accumulation of cholesterol in lysosomes, with delayed induction of cholesterol homeostatic reactions. Niemann-Pick disease type C1 has a highly variable clinical phenotype. Clinical features include variable hepatosplenomegaly and severe progressive neurological dysfunction such as ataxia, dystonia and dementia. The age of onset can vary from infancy to late adulthood. An allelic variant of Niemann-Pick disease type C1 is found in people with Nova Scotia ancestry. Patients with the Nova Scotian clinical variant are less severely affected.
Spastic paraplegia 39, autosomal recessive
A form of spastic paraplegia, a neurodegenerative disorder characterized by a slow, gradual, progressive weakness and spasticity of the lower limbs. Rate of progression and the severity of symptoms are quite variable. Initial symptoms may include difficulty with balance, weakness and stiffness in the legs, muscle spasms, and dragging the toes when walking. In some forms of the disorder, bladder symptoms (such as incontinence) may appear, or the weakness and stiffness may spread to other parts of the body. SPG39 is associated with a motor axonopathy affecting upper and lower limbs and resulting in progressive wasting of distal upper and lower extremity muscles.
Multiple sulfatase deficiency
A clinically and biochemically heterogeneous disorder caused by the simultaneous impairment of all sulfatases, due to defective post-translational modification and activation. It combines features of individual sulfatase deficiencies such as metachromatic leukodystrophy, mucopolysaccharidosis, chondrodysplasia punctata, hydrocephalus, ichthyosis, neurologic deterioration and developmental delay.
Ichthyosis, X-linked
A keratinization disorder manifesting with mild erythroderma and generalized exfoliation of the skin within a few weeks after birth. Affected boys later develop large, polygonal, dark brown scales, especially on the neck, extremities, trunk, and buttocks.
Frontotemporal dementia 2
A form of dementia characterized by pathologic finding of frontotemporal lobar degeneration, presenile dementia with behavioral changes, deterioration of cognitive capacities and loss of memory. Gestural apraxia, parkinsonism, visual loss, and visual hallucinations are present in 25 to 40% of patients.
Muscular dystrophy, congenital, megaconial type
An autosomal recessive, congenital muscular dystrophy characterized by early-onset muscle wasting, intellectual disability, and dilated cardiomyopathy in half of affected individuals. Some patients may die from cardiomyopathy in the first or second decade of life. Muscle biopsy shows peculiar enlarged mitochondria that are prevalent toward the periphery of the fibers but are sparse in the center.
Chondrodysplasia punctata 1, X-linked recessive
A clinically and genetically heterogeneous disorder characterized by punctiform calcification of the bones. CDPX1 is a congenital defect of bone and cartilage development characterized by aberrant bone mineralization, severe underdevelopment of nasal cartilage, and distal phalangeal hypoplasia. This disease can also be induced by inhibition with the drug warfarin.
Alpha-methylacyl-CoA racemase deficiency
A rare autosomal recessive peroxisomal disorder characterized by elevated plasma concentrations of pristanic acid C27-bile-acid intermediates, and adult onset of variable neurodegenerative symptoms affecting the central and peripheral nervous systems. Features may include seizures, visual failure, sensorimotor neuropathy, spasticity, migraine, and white matter hyperintensities on brain imaging.
Tangier disease
An autosomal recessive disorder characterized by near absence of plasma high density lipoproteins, low serum HDL cholesterol, and massive tissue deposition of cholesterol esters. Clinical features include large yellow-orange tonsils, hepatomegaly, splenomegaly, enlarged lymph nodes, and often sensory polyneuropathy.
Congenital bile acid synthesis defect 2
A condition characterized by jaundice, intrahepatic cholestasis and hepatic failure. Patients with this liver disease show absence or low levels of chenodeoxycholic acid and cholic acid in plasma and urine.
Hypobetalipoproteinemia, familial, 1
A disorder of lipid metabolism characterized by less than 5th percentile age- and sex-specific levels of low density lipoproteins, and dietary fat malabsorption. Clinical presentation may vary from no symptoms to severe gastrointestinal and neurological dysfunction similar to abetalipoproteinemia.
Hypertriglyceridemia 1
A common inherited disorder in which the concentration of very low density lipoprotein (VLDL) is elevated in the plasma. This leads to increased risk of heart disease, obesity, and pancreatitis. Inheritance is autosomal dominant.
Acyl-CoA dehydrogenase very long-chain deficiency
An inborn error of mitochondrial fatty acid beta-oxidation which leads to impaired long-chain fatty acid beta-oxidation. It is clinically heterogeneous, with three major phenotypes: a severe childhood form characterized by early onset, high mortality and high incidence of cardiomyopathy; a milder childhood form with later onset, characterized by hypoketotic hypoglycemia, low mortality and rare cardiomyopathy; an adult form, with isolated skeletal muscle involvement, rhabdomyolysis and myoglobinuria, usually triggered by exercise or fasting.
Gallbladder disease 4
One of the major digestive diseases. Gallstones composed of cholesterol (cholelithiasis) are the common manifestations in western countries. Most people with gallstones, however, remain asymptomatic through their lifetimes.
Ceroid lipofuscinosis, neuronal, 8
A form of neuronal ceroid lipofuscinosis with onset in childhood. Neuronal ceroid lipofuscinoses are progressive neurodegenerative, lysosomal storage diseases characterized by intracellular accumulation of autofluorescent liposomal material, and clinically by seizures, dementia, visual loss, and/or cerebral atrophy. The lipopigment patterns observed most often in neuronal ceroid lipofuscinosis type 8 comprise mixed combinations of granular, curvilinear, and fingerprint profiles.
Sjoegren-Larsson syndrome
An autosomal recessive neurocutaneous disorder characterized by a combination of severe intellectual disability, spastic di- or tetraplegia and congenital ichthyosis. Ichthyosis is usually evident at birth with varying degrees of erythema and scaling, neurologic symptoms appear in the first or second year of life. Most patients have an IQ of less than 60. Additional clinical features include glistening white spots on the retina, seizures, short stature and speech defects.
Adrenal hyperplasia 3
A form of congenital adrenal hyperplasia, a common recessive disease due to defective synthesis of cortisol. Congenital adrenal hyperplasia is characterized by androgen excess leading to ambiguous genitalia in affected females, rapid somatic growth during childhood in both sexes with premature closure of the epiphyses and short adult stature. Four clinical types: 'salt wasting' (SW, the most severe type), 'simple virilizing' (SV, less severely affected patients), with normal aldosterone biosynthesis, 'non-classic form' or late-onset (NC or LOAH) and 'cryptic' (asymptomatic).
Sitosterolemia 2
A form of sitosterolemia, an autosomal recessive metabolic disorder characterized by unregulated intestinal absorption of cholesterol, phytosterols and shellfish sterols, and decreased biliary excretion of dietary sterols into bile. Patients have hypercholesterolemia, very high levels of plant sterols in the plasma, and frequently develop tendon and tuberous xanthomas, accelerated atherosclerosis and premature coronary artery disease.
Hyperlipoproteinemia 1B
Autosomal recessive trait characterized by hypertriglyceridemia, xanthomas, and increased risk of pancreatitis and early atherosclerosis.
Cardiomyopathy, dilated, 2H
A form of dilated cardiomyopathy, a disorder characterized by ventricular dilation and impaired systolic function, resulting in congestive heart failure and arrhythmia. Patients are at risk of premature death. CMD2H is an autosomal recessive form characterized by rapid progression and death in early infancy.
Medicamentos e terapias
Mecanismo: HMG-CoA reductase inhibitor
Mecanismo: Niemann-Pick C1-like protein 1 inhibitor
Mecanismo: Voltage-gated L-type calcium channel blocker
Mecanismo: HMG-CoA reductase inhibitor
Mecanismo: Subtilisin/kexin type 9 inhibitor
Mecanismo: Subtilisin/kexin type 9 inhibitor
Mecanismo: Angiopoietin-related protein 3 inhibitor
Mecanismo: ATP-citrate synthase inhibitor
Mecanismo: HMG-CoA reductase inhibitor
Mecanismo: Apo-B 100 mRNA antisense inhibitor
Variantes genéticas (ClinVar)
706 variantes patogênicas registradas no ClinVar.
Vias biológicas (Reactome)
169 vias biológicas associadas aos genes desta condição.
Diagnóstico
Os sinais que médicos procuram e os exames que confirmam
Tratamento e manejo
Remédios, cuidados de apoio e o que precisa acompanhar
Onde tratar no SUS
Hospitais de referência no Brasil e o protocolo oficial do SUS (PCDT)
🇧🇷 Atendimento SUS — Alteração do metabolismo lipídico
Centros de Referência SUS
21 centros habilitados pelo SUS para Alteração do metabolismo lipídico
Centros para Alteração do metabolismo lipídico
Detalhes dos centros
Hospital Universitário Prof. Edgard Santos (HUPES)
R. Dr. Augusto Viana, s/n - Canela, Salvador - BA, 40110-060 · CNES 0003808
Serviço de Referência
Hospital de Apoio de Brasília (HAB)
AENW 3 Lote A Setor Noroeste - Plano Piloto, Brasília - DF, 70684-831 · CNES 0010456
Serviço de Referência
Hospital Estadual Infantil e Maternidade Alzir Bernardino Alves (HIABA)
Av. Min. Salgado Filho, 918 - Soteco, Vila Velha - ES, 29106-010 · CNES 6631207
Serviço de Referência
Hospital das Clínicas da UFG
Rua 235 QD. 68 Lote Área, Nº 285, s/nº - Setor Leste Universitário, Goiânia - GO, 74605-050 · CNES 2338424
Serviço de Referência
Hospital das Clínicas da UFMG
Av. Prof. Alfredo Balena, 110 - Santa Efigênia, Belo Horizonte - MG, 30130-100 · CNES 2280167
Serviço de Referência
NUPAD / Faculdade de Medicina UFMG
Av. Prof. Alfredo Balena, 189 - 5 andar - Centro, Belo Horizonte - MG, 30130-100 · CNES 2183226
Serviço de Referência
Hospital Universitário João de Barros Barreto
R. dos Mundurucus, 4487 - Guamá, Belém - PA, 66073-000 · CNES 2337878
Serviço de Referência
Hospital de Clínicas da Universidade Federal de Pernambuco
Av. Prof. Moraes Rego, 1235 - Cidade Universitária, Recife - PE, 50670-901 · CNES 2561492
Atenção Especializada
Instituto de Medicina Integral Prof. Fernando Figueira (IMIP)
R. dos Coelhos, 300 - Boa Vista, Recife - PE, 50070-902 · CNES 0000647
Serviço de Referência
Hospital de Clínicas da UFPR
R. Gen. Carneiro, 181 - Alto da Glória, Curitiba - PR, 80060-900 · CNES 2364980
Serviço de Referência
Hospital Universitário Pedro Ernesto (HUPE-UERJ)
Blvd. 28 de Setembro, 77 - Vila Isabel, Rio de Janeiro - RJ, 20551-030 · CNES 2280221
Serviço de Referência
Instituto Nacional de Saúde da Mulher, da Criança e do Adolescente Fernandes Figueira (IFF/Fiocruz)
Av. Rui Barbosa, 716 - Flamengo, Rio de Janeiro - RJ, 22250-020 · CNES 2269988
Serviço de Referência
Hospital Universitário Onofre Lopes (HUOL)
Av. Nilo Peçanha, 620 - Petrópolis, Natal - RN, 59012-300 · CNES 2408570
Atenção Especializada
Hospital São Lucas da PUCRS
Av. Ipiranga, 6690 - Jardim Botânico, Porto Alegre - RS, 90610-000 · CNES 2232928
Serviço de Referência
Hospital de Clínicas de Porto Alegre (HCPA)
Rua Ramiro Barcelos, 2350 Bloco A - Av. Protásio Alves, 211 - Bloco B e C - Santa Cecília, Porto Alegre - RS, 90035-903 · CNES 2237601
Serviço de Referência
Hospital Universitário da UFSC (HU-UFSC)
R. Profa. Maria Flora Pausewang - Trindade, Florianópolis - SC, 88036-800 · CNES 2560356
Serviço de Referência
Hospital das Clínicas da FMUSP
R. Dr. Ovídio Pires de Campos, 225 - Cerqueira César, São Paulo - SP, 05403-010 · CNES 2077485
Serviço de Referência
Hospital de Clínicas da UNICAMP
R. Vital Brasil, 251 - Cidade Universitária, Campinas - SP, 13083-888 · CNES 2748223
Serviço de Referência
Hospital de Clínicas de Ribeirão Preto (HCRP-USP)
R. Ten. Catão Roxo, 3900 - Vila Monte Alegre, Ribeirão Preto - SP, 14015-010 · CNES 2082187
Serviço de Referência
Instituto da Criança e do Adolescente (ICr-HCFMUSP)
Av. Dr. Enéas Carvalho de Aguiar, 647 - Cerqueira César, São Paulo - SP, 05403-000 · CNES 2081695
Serviço de Referência
UNIFESP / Hospital São Paulo
R. Napoleão de Barros, 715 - Vila Clementino, São Paulo - SP, 04024-002 · CNES 2688689
Serviço de Referência
Dados de DATASUS/CNES, SBGM, ABNeuro e Ministério da Saúde. Sempre confirme a disponibilidade diretamente com o estabelecimento.
Pesquisa ativa
Ensaios clínicos abertos e novidades científicas recentes
Ensaios em destaque
Com ensaio aberto em 21 países. O ponto verde marca onde há vaga agora.
🟢 Recrutando agora
22 pesquisas recrutando participantes. Converse com seu médico sobre a possibilidade de participar.
Outros ensaios clínicos
176 ensaios clínicos encontrados, 37 ativos.
Publicações mais relevantes
Sitosterolemia Presenting as Lipid Keratopathy and Xanthomas.
Sitosterolemia is a rare autosomal recessive disorder of lipid metabolism, with varied incidence rates of 1/200 000 to 1/1 000 000. The condition often presents prepubertally, but is commonly misdiagnosed as familial hypercholesterolemia. We want to raise clinical suspicion across pediatric generalists and subspecialties with our case report of a 7-year-old girl who presented via ophthalmology following the surgical removal of a lipid keratopathy of her cornea. Four years before her presentation at ophthalmology, she also underwent surgical excision of a large xanthoma from her left buttock. There was no further diagnostic workup at that point. On examination, she had multiple tuberous xanthomas on her knuckles and knees in addition to the corneal deposits. Baseline lipid investigation revealed a markedly elevated total cholesterol of 11.9 mmol/L and an LDL cholesterol of 10.2 mmol/L. She was given a presumptive diagnosis of familial hypercholesterolemia and started on statin therapy, to which she had a partial response. Molecular genetic analysis for familial hypercholesterolemia was negative, but because of the high index of suspicion, an expanded genetics panel was requested that demonstrated compound heterozygous variants in the ABCG5 gene, pathogenic for sitosterolemia. Sterol analysis demonstrated markedly elevated phytosterol levels consistent with the genetic findings. The patient was treated with dietary restriction of plant sterols and Ezetimibe. Computed tomography coronary angiogram showed no coronary artery calcification. An awareness of sitosterolemia amongst pediatricians is vitally important as this condition may present to numerous specialties, as evidenced in this case. Recommended lifestyle and pharmacotherapy interventions differ between sitosterolemia and familial hypercholesterolemia.
Lipid Keratopathy in Sitosterolemia: A Case Report and Review of The Ophthalmic Manifestations.
The aim of this study was to describe the case of a 9-year-old girl with inferior arcus in her right cornea and discrete inferior lipid deposition in her left cornea. Serum cholesterol and lipid levels were measured under general anesthesia for treatment with fine-needle cautery and subconjunctival bevacizumab. Serum cholesterol and low-density lipoprotein were elevated at 12 mmol/L (normal range 3-5 mmol/L) and 10.8 mmol/L (normal range <3 mmol/L), respectively. Genetic testing identified a pathogenic variant in the ATP-binding cassette subfamily G member 5 (ABCG5) gene consistent with sitosterolemia, a rare, autosomal recessive disorder of lipid metabolism. Mutations in the ABC genes result in ineffective transport of plant sterols into the intestinal lumen and their subsequent accumulation in the blood. The girl's cholesterol and lipid profile returned to normal following dietary restriction of plant sterol intake and treatment with ezetimibe 10 mg daily and atorvastatin 10 mg daily. This is the first reported case of a discrete lipid deposit at the cornea in a patient with sitosterolemia. Untreated, patients with sitosterolemia can develop coronary artery disease early in life. Ophthalmologists should be aware of the potential for underlying disorders of lipid metabolism in young patients with corneal arcus and/or lipid keratopathy.
Panaxatriol Improves the Disorder of Lipid Metabolism and Intestinal Flora in Rats Fed With a High-Fat Diet.
The ability of ginsenosides to regulate lipid metabolism in vivo and in vitro has been widely studied; however, the effect of panaxatriol (PT) on reducing blood lipids and its impact on intestinal microflora have not been investigated. The results of this study show that PT can not only significantly reduce the level of ALT but also effectively alleviate fatty degeneration and lipid droplet deposition in hepatocytes, thereby improving the pathological damage to the liver. It can also significantly reduce serum TC, TG, and LDL-C levels and increase HDL-C. At the same time, PT can significantly increase SOD activity, decrease MDA content, and inhibit the increase of coagulation factors such as TXB2, thus alleviating vascular endothelial injury. In addition, PT decreased the abundance of intestinal flora, increased the ratio of Firmicutes to Bacteroidetes, increased the abundance of Akkermansia, and decreased the abundance of Prevotella. Our research shows that PT can effectively alleviate the lipid metabolism disorder induced by the high-fat and high-sugar diet by improving liver lipid deposition, enhancing antioxidant capacity, regulating blood coagulation function, and reshaping intestinal flora structure, suggesting that PT has potential application value in the treatment of metabolic syndrome.
Lecithin-Cholesterol Acyltransferase Deficiency as a Rare Cause of Bilateral Corneal Opacities: A Case Report of a Novel Frameshift Mutation.
Lecithin-cholesterol acyltransferase (LCAT) deficiency is a rare autosomal recessive disorder of lipid metabolism characterized by corneal opacification, hemolytic anemia, and chronic kidney disease. We describe the ophthalmic, systemic, and genetic findings of a patient with LCAT deficiency and report a novel frameshift mutation in the LCAT gene. Ophthalmic findings may represent the first clinical sign and guide the diagnosis. A 50-year-old white male with end-stage renal disease on hemodialysis and a history of recurrent hemolytic anemia was referred for bilateral corneal opacities. Despite diffuse opacification involving all corneal layers, his best corrected visual acuity remained 20/20 in both eyes with normal color vision, although contrast sensitivity was reduced. Laboratory testing revealed normocytic, normochromic anemia, low HDL cholesterol, and reduced apolipoprotein A levels. Genetic analysis identified compound heterozygosity in the LCAT gene: a novel frameshift variant c.580_598del p.(Ala194Serfs*64), classified as likely pathogenic, and the previously described missense variant c.619G>A p.(Gly207Ser), also classified as likely pathogenic. This case highlights the importance of considering metabolic disorders in the differential diagnosis of bilateral corneal opacities and expands the genetic spectrum of LCAT deficiency by reporting a novel frameshift mutation.
The novel_miR-123 targets SeFas4 to inhibit lipogenesis of Spodoptera exigua post Bacillus thuringiensis GS57 infection.
The infection of Bacillus thuringiensis (Bt) could inhibit the growth and development of the pest by impairing its lipid metabolism. Although miRNAs have been proven to be involved in insect development, reproduction, and immune response, the role of miRNAs in regulating the disorder of lipid metabolism caused by Bt infection remains unclear at the post-transcriptional level. In this study, we found that novel_miR-123 responding to Bt infection was accounted for downregulating the expression of SeFas4 to inhibit the lipogenesis, which lead to delayed development, shortened lifespan, and reduced reproduction of Spodoptera exigua. The regulation relationship between novel_miR-123 and its target gene SeFas4 was subsequently identified using mimics and inhibitor injection, Dual-luciferase reporter assay, and rescue assay. Moreover, the overexpression of novel_miR-123 resulted in reduced lipid accumulation and delayed development, whereas the knockdown of novel_miR-123 resulted in weight gain and excessive lipid accumulation of S. exigua. The rescue assay showed that novel_miR-123 inhibitor could alleviate delayed weight development induced by dsSeFas4, as well as restore the reduced lipid accumulation of S. exigua. In addition, the monitoring of gene expression showed that the novel_miR-123 and SeFas4 mainly responded to Bt GS57 infection in the larval duration stage, implying the important role in larval lipid accumulation. Our findings provide a new insight into the regulation pathway of pest development impaired by Bt infection, consequently identifying a promising target for the development of pest control strategies.
Publicações recentes
Case Report: Compound heterozygous familial hypercholesterolemia in a pediatric patient with multiple cutaneous xanthomas.
Carnitine Palmitoyltransferase II Deficiency.
Lipid Keratopathy in Sitosterolemia: A Case Report and Review of The Ophthalmic Manifestations.
Panaxatriol Improves the Disorder of Lipid Metabolism and Intestinal Flora in Rats Fed With a High-Fat Diet.
Lecithin-Cholesterol Acyltransferase Deficiency as a Rare Cause of Bilateral Corneal Opacities: A Case Report of a Novel Frameshift Mutation.
📚 EuropePMC26 artigos no totalmostrando 178
Lipid Keratopathy in Sitosterolemia: A Case Report and Review of The Ophthalmic Manifestations.
CorneaPanaxatriol Improves the Disorder of Lipid Metabolism and Intestinal Flora in Rats Fed With a High-Fat Diet.
Chemistry & biodiversityLecithin-Cholesterol Acyltransferase Deficiency as a Rare Cause of Bilateral Corneal Opacities: A Case Report of a Novel Frameshift Mutation.
Case reports in ophthalmologySitosterolemia Presenting as Lipid Keratopathy and Xanthomas.
PediatricsThe novel_miR-123 targets SeFas4 to inhibit lipogenesis of Spodoptera exigua post Bacillus thuringiensis GS57 infection.
Pesticide biochemistry and physiologyPsychological Framing of Illness: Early Family Trauma and Diagnostic Delay in Adult-Onset Metachromatic Leukodystrophy.
Case reports in psychiatryImperatorin ameliorates metabolic dysfunction-associated fatty liver disease through modulating Suv39h1/Fabps/Cept1 signalling pathway.
British journal of pharmacologyUnfriendly dialogue of gut microbiota and lipid metabolism in Alzheimer's disease.
Journal of Alzheimer's disease : JADIdentification of Riboflavin Metabolism Pathway in HepG2 Cells Expressing Genotype IV Swine Hepatitis E Virus ORF3 Protein.
Veterinary sciencesState-of-the-art review: The value of leveraging evidence and data (LEAD) in pediatric screening for familial hypercholesterolemia.
American journal of preventive cardiologyEffect of pemafibrate on high-density lipoprotein cholesterol levels and subspecies in a patient with cholesteryl ester transfer protein deficiency: A case report with mechanistic insights.
Journal of clinical lipidologyResearch advances in current drugs targeting hyperlipidemia (Review).
Molecular medicine reportsRole of Next-Generation Sequencing in Diagnosis of Familial Hypercholesterolemia in Serbia.
Diagnostics (Basel, Switzerland)Roles of ABCA1 in Chronic Obstructive Pulmonary Disease.
COPDA Novel Screening Approach for Familial Hypercholesterolemia: A Genetic Study on Patients Detected Using Preexisting Centralized Analytics.
Journal of clinical medicineUnveiling the roles of HIPK2 in atherosclerosis: Insights into the β-catenin/STAT1 signaling cascade and the involvement of SENP1.
Biochemical pharmacologyHow fish intestinal cells responded to dietary methylmercury exposure? A single-cell transcriptomic analysis.
Environmental pollution (Barking, Essex : 1987)Proteomic analysis reveals the alleviation of follicular development defects in offspring mice under DEHP exposure by melatonin.
BMC biologyEfficacy and safety of ongericimab in Chinese patients with heterozygous familial hypercholesterolemia: A randomized, double-blind, placebo-controlled phase 3 trial.
AtherosclerosisHigh burden of disease in patients with homozygous familial hypercholesterolemia despite recent advances in therapies and updated guidelines: A real-world study.
Journal of clinical lipidologyResearch Progress on Obesity-Associated Kidney Diseases.
Zhongguo yi xue ke xue yuan xue bao. Acta Academiae Medicinae SinicaeTherapeutic Persistence in the Management of Familial Hypercholesterolemia: A Case of Acquired PCSK9 Inhibitor Nonresponse.
JACC. Case reports[Thyroid Hormone Resistance Syndrome Complicated With Papillary Thyroid Carcinoma and Madelung's Disease:Report of One Case].
Zhongguo yi xue ke xue yuan xue bao. Acta Academiae Medicinae SinicaeUnveiling the comorbidity burden of male breast cancer.
Scientific reportsBisphenol A induces lipid metabolism disorder and impairs hepatopancreas of Sesarmops sinensis.
Marine pollution bulletinDilated cardiomyopathy revealing Refsum disease: a case report.
Journal of medical case reportsEffect of electroacupuncture on the intestinal flora-short chain fatty acid metabolism axis in simple obesity rats.
Zhen ci yan jiu = Acupuncture researchInsulin-like growth factor-binding protein 7 exacerbates inflammatory response and lipid metabolism imbalance in alcohol-associated liver disease.
Free radical biology & medicineAstragaloside IV attenuates fatty acid-induced renal tubular injury in diabetic kidney disease by inhibiting fatty acid transport protein-2.
Phytomedicine : international journal of phytotherapy and phytopharmacologyThe Correlation between Depression during Pregnancy and Metabolic Syndrome.
Actas espanolas de psiquiatriaBeneficial effects of Dendrobium officinale National Herbal Drink on metabolic immune crosstalk via regulate SCFAs-Th17/Treg.
Phytomedicine : international journal of phytotherapy and phytopharmacologyFagopyrum Dibotrys Rhizoma regulates pulmonary lipid metabolic homeostasis and the ERK-cPLA2 pathway to alleviate asthma in mice.
Phytomedicine : international journal of phytotherapy and phytopharmacologyImplementation of a primary-tertiary shared care model to improve the detection of familial hypercholesterolaemia (FH): a mixed methods pre-post implementation study protocol.
BMJ openEffect of circadian rhythm change on gut microbiota and the development of nonalcoholic fatty liver disease in mice.
Sleep medicineDietary pterostilbene exerts potential protective effects by regulating lipid metabolism and enhancing antioxidant capacity on liver in broilers.
Journal of animal physiology and animal nutritionACOX1 deficiency-induced lipid metabolic disorder facilitates chronic interstitial fibrosis development in renal allografts.
Pharmacological researchFamilial ApoB-specific familial hypobetalipoproteinemia in a patient with non-classical congenital adrenal hyperplasia.
Clinica e investigacion en arteriosclerosis : publicacion oficial de la Sociedad Espanola de ArteriosclerosisAnalysis of fecal microbiome and metabolome changes in goats with pregnant toxemia.
BMC veterinary researchPromote lipolysis in white adipocytes by magnetic hyperthermia therapy with Fe3O4microsphere-doped hydrogel.
NanotechnologyPolymethoxyflavones in citrus extract has a beneficial effect on hypercholesterolemia rats by promoting liver cholesterol metabolism.
Journal of ethnopharmacologyUnraveling the genetic background of individuals with a clinical familial hypercholesterolemia phenotype.
Journal of lipid researchWhole grain germinated brown rice intake modulates the gut microbiota and alleviates hypertriglyceridemia and hypercholesterolemia in high fat diet-fed mice.
Food & functionMetabolomics analysis delineates the therapeutic effects of Yinlan Tiaozhi capsule on triton WR-1339 -induced hyperlipidemia in mice.
Frontiers in pharmacologyFamilial hypercholesterolemia and its manifestations: Practical considerations for general practitioners.
Kardiologia polskaIsophorone-based AIEgens fluorescent probe with red emission for targeting lipid droplets and identifying non-alcoholic fatty liver disease.
Spectrochimica acta. Part A, Molecular and biomolecular spectroscopyLipidomic analysis identified potential predictive biomarkers of statin response in subjects with Familial hypercholesterolemia.
Chemistry and physics of lipidsHigh-Throughput Microscopy Characterization of Rare LDLR Variants.
JACC. Basic to translational scienceLipid metabolism disorder promotes the development of intervertebral disc degeneration.
Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapieIntegration of transcriptomics and metabolomics analysis for unveiling the toxicological profile in the liver of mice exposed to uranium in drinking water.
Environmental pollution (Barking, Essex : 1987)An increase in calculated small dense low-density lipoprotein cholesterol predicts new onset of hypertension in a Japanese cohort.
Hypertension research : official journal of the Japanese Society of HypertensionIntegrated Analysis of Transcriptome and Metabolome Provides Insight into Camellia oleifera Oil Alleviating Fat Accumulation in High-Fat Caenorhabditis elegans.
International journal of molecular sciencesThe anti-hyperlipidemic effect and underlying mechanisms of barley (Hordeum vulgare L.) grass polysaccharides in mice induced by a high-fat diet.
Food & functionGinsenosides Rg1 regulate lipid metabolism and temperature adaptation in Caenorhabditis elegans.
Journal of ginseng researchStudy on the therapeutic effect and mechanism of Tangningtongluo Tablet on diabetic mice.
Journal of diabetes and its complicationsRegulation of endothelial ferroptosis by SESN1 in atherosclerosis and its related mechanism.
AgingNiclosamide exposure disrupts antioxidant defense, histology, and the liver and gut transcriptome of Chinese soft-shelled turtle (Pelodiscus sinensis).
Ecotoxicology and environmental safety[Blueberry attenuates liver injury in metabolic dysfunction-associated liver disease by promoting the expression of mitofilin/Mic60 in human hepatocytes and inhibiting the production of superoxide].
Xi bao yu fen zi mian yi xue za zhi = Chinese journal of cellular and molecular immunologyGlutaminase 1 isoform up-regulation associated with lipid metabolism disorder induced by methyl tertiary-butyl ether in male rats.
Ecotoxicology and environmental safetyMembrane Protein Amuc_1100 Derived from Akkermansia muciniphila Facilitates Lipolysis and Browning via Activating the AC3/PKA/HSL Pathway.
Microbiology spectrumLysophosphatidylcholine inhibits lung cancer cell proliferation by regulating fatty acid metabolism enzyme long-chain acyl-coenzyme A synthase 5.
Clinical and translational medicineFenofibrate suppresses corneal neovascularization by regulating lipid metabolism through PPARα signaling pathway.
Frontiers in pharmacologyEffect of Lactobacillus rhamnosus hsryfm 1301 Fermented Milk on Lipid Metabolism Disorders in High-Fat-Diet Rats.
NutrientsProgressive ataxia of cerebrotendinous xanthomatosis with a rare c.255+1G>T splice site mutation: A case report.
World journal of clinical casesComparison of developmental toxicity induced by PFOA, HFPO-DA, and HFPO-TA in zebrafish embryos.
ChemosphereFamilial Hypercholesterolaemia as a Predisposing Factor for Atherosclerosis.
BiomedicinesKaempferol attenuates nonalcoholic steatohepatitis by regulating serum and liver bile acid metabolism.
Frontiers in pharmacologyCompound green tea (CGT) regulates lipid metabolism in high-fat diet induced mice.
RSC advancesModulation of the gut microbiota and lipidomic profiles by black chokeberry (Aronia melanocarpa L.) polyphenols via the glycerophospholipid metabolism signaling pathway.
Frontiers in nutritionRoles of organelle-specific autophagy in hepatocytes in the development and treatment of non-alcoholic fatty liver disease.
Chinese medical journalLandscape of lipidomic metabolites in gut-liver axis of Sprague-Dawley rats after oral exposure to titanium dioxide nanoparticles.
Particle and fibre toxicologyToxicity of triphenyl phosphate toward the marine rotifer Brachionus plicatilis: Changes in key life-history traits, rotifer-algae population dynamics and the metabolomic response.
Ecotoxicology and environmental safetyInhibition of epigenetic reader proteins by apabetalone counters inflammation in activated innate immune cells from Fabry disease patients receiving enzyme replacement therapy.
Pharmacology research & perspectivesMagnesium isoglycyrrhizinate attenuates acute alcohol-induced hepatic steatosis in a zebrafish model by regulating lipid metabolism and ER stress.
Nutrition & metabolismAdipose Dysfunction in Adulthood Insulin Resistance of Low-Birth Weight Mice: A Proteomics Study.
Diabetes, metabolic syndrome and obesity : targets and therapyQuantitative proteomics analysis based on tandem mass tag labeling coupled with labeling coupled with liquid chromatography-tandem mass spectrometry discovers the effect of silibinin on non-alcoholic fatty liver disease in mice.
BioengineeredIntegrated application of multi-omics approach and biochemical assays provides insights into physiological responses to saline-alkaline stress in the gills of crucian carp (Carassius auratus).
The Science of the total environmentIncidental diagnosis of LPL deficiency in an infant presenting with an acute respiratory infection.
Clinica chimica acta; international journal of clinical chemistryHematological Inflammatory Markers in Patients with Clinically Confirmed Familial Hypercholesterolemia.
BioMed research internationalPerformance comparison of different classification algorithms applied to the diagnosis of familial hypercholesterolemia in paediatric subjects.
Scientific reportsCurcumin ameliorates lipid metabolic disorder and cognitive dysfunction via the ABCA1 transmembrane transport system in APP/PS1 double transgenic mice.
Journal of integrative neuroscienceTilapia Head Protein Hydrolysate Attenuates Scopolamine-Induced Cognitive Impairment through the Gut-Brain Axis in Mice.
Foods (Basel, Switzerland)Lipopolysaccharide and tyloxapol accelerate the development of atherosclerosis in mice.
LipidsMadelung's disease with alcoholic liver disease and acute kidney injury: A case report.
World journal of clinical casesCharacterization of Two Variants at Met 1 of the Human LDLR Gene Encoding the Same Amino Acid but Causing Different Functional Phenotypes.
BiomedicinesThe Effects of Diosgenin on Hypolipidemia and Its Underlying Mechanism: A Review.
Diabetes, metabolic syndrome and obesity : targets and therapyPremature Acute Myocardial Infarction in a Young Patient With Sitosterolemia.
CJC openIntegrated metabolome and transcriptome analyses revealing the effects of thermal stress on lipid metabolism in juvenile turbot Scophthalmus maximus.
Journal of thermal biologyDietary Sterols and Sterol Oxidation Products on Atherosclerosis: An Insight Provided by Liver Proteomic and Lipidomic.
Molecular nutrition & food researchLDLR variants functional characterization: Contribution to variant classification.
AtherosclerosisSpatially Resolved Metabolomics Based on Air-Flow-Assisted Desorption Electrospray Ionization-Mass Spectrometry Imaging Reveals Region-Specific Metabolic Alterations in Diabetic Encephalopathy.
Journal of proteome researchEffects of high-fat diet on the formation of depressive-like behavior in mice.
Food & functionHigh Fat Activates O-GlcNAcylation and Affects AMPK/ACC Pathway to Regulate Lipid Metabolism.
NutrientsGinsenoside CK inhibits obese insulin resistance by activating PPARγ to interfere with macrophage activation.
Microbial pathogenesisAdipose tissue of female Wistar rats respond to Ilex paraguariensis treatment after ovariectomy surgery.
Journal of traditional and complementary medicine[Effect of the reactive oxygen species-induced by bisphenol A on liver lipid metabolism disorder].
Wei sheng yan jiu = Journal of hygiene researchMetabolic profiling of fatty acids in Tripterygium wilfordii multiglucoside- and triptolide-induced liver-injured rats.
Open life sciencesHow registers could enhance knowledge and characterization of genetic dyslipidaemias: The experience of the LIPIGEN in Italy and of other networks for familial hypercholesterolemia.
Atherosclerosis. SupplementsApigenin Ameliorates Insulin Resistance and Lipid Accumulation by Endoplasmic Reticulum Stress and SREBP-1c/SREBP-2 Pathway in Palmitate-Induced HepG2 Cells and High-Fat Diet-Fed Mice.
The Journal of pharmacology and experimental therapeuticsPotential mechanisms underlying the ameliorative effect of Lactobacillus paracasei FZU103 on the lipid metabolism in hyperlipidemic mice fed a high-fat diet.
Food research international (Ottawa, Ont.)Lipid metabolism-related proteins of relevant evolutionary and lymphoid interest (PRELI) domain containing family proteins in cancer.
American journal of translational researchStudy on the attenuated effect of Ginkgolide B on ferroptosis in high fat diet induced nonalcoholic fatty liver disease.
ToxicologyHomozygous autosomal recessive hypercholesterolaemia in a South Asian child presenting with multiple cutaneous xanthomata.
Annals of clinical biochemistryEffects of epoxy stearic acid on lipid metabolism in HepG2 cells.
Journal of food scienceCascade screening and treatment of children with familial hypercholesterolemia in Turkey.
Journal of pediatric endocrinology & metabolism : JPEMRegulatory roles of circRNAs in adipogenesis and lipid metabolism: emerging insights into lipid-related diseases.
The FEBS journalAssociation of body mass index changes from childhood to adulthood with dyslipidemia in adults: Hanzhong adolescent cohort study.
Journal of public health (Oxford, England)Volanesorsen in the Treatment of Familial Chylomicronemia Syndrome or Hypertriglyceridaemia: Design, Development and Place in Therapy.
Drug design, development and therapyThe crosstalk: exosomes and lipid metabolism.
Cell communication and signaling : CCSMultiomics Profiling Reveals Protective Function of Schisandra Lignans against Acetaminophen-Induced Hepatotoxicity.
Drug metabolism and disposition: the biological fate of chemicalsEvaluation of efficacy and safety of antisense inhibition of apolipoprotein C-III with volanesorsen in patients with severe hypertriglyceridemia.
Expert opinion on pharmacotherapyThe "discovery" of lipid droplets: A brief history of organelles hidden in plain sight.
Biochimica et biophysica acta. Molecular and cell biology of lipidsGenetic, biochemical, and clinical features of LCAT deficiency: update for 2020.
Current opinion in lipidology5α,6α-Epoxyphytosterols and 5α,6α-Epoxycholesterol Increase Nitrosative Stress and Inflammatory Cytokine Production in Rats on Low-Cholesterol Diet.
Oxidative medicine and cellular longevityMultimodality imaging approach to Fabry cardiomyopathy: Any role for nuclear cardiology?
Journal of nuclear cardiology : official publication of the American Society of Nuclear CardiologyFever, Fasting, and Rhabdomyolysis in an Adult Male.
Neurology IndiaVirtual genetic diagnosis for familial hypercholesterolemia powered by machine learning.
European journal of preventive cardiologyThe Lipo- Phenotypic Screening Tool for Familial Hypercholesterolaemia.
JPMA. The Journal of the Pakistan Medical AssociationTranscriptome analysis reveals mechanism underlying the differential intestinal functionality of laying hens in the late phase and peak phase of production.
BMC genomicsSimilar hepatotoxicity response induced by Rhizoma Paridis in zebrafish larvae, cell and rat.
Journal of ethnopharmacologyEffects of di (2-ethylhexyl) phthalate and high-fat diet on lipid metabolism in rats by JAK2/STAT5.
Environmental science and pollution research internationalDetermination of the Pathological Features of NPC1 Variants in a Cellular Complementation Test.
International journal of molecular sciencesProtective Effects and Mechanisms of Vaccarin on Vascular Endothelial Dysfunction in Diabetic Angiopathy.
International journal of molecular sciencesEffects of fluoride on the histology, lipid metabolism, and bile acid secretion in liver of Bufo gargarizans larvae.
Environmental pollution (Barking, Essex : 1987)Identifying obesity-related multimorbidity combinations in the United States.
Clinical obesityAnthraquinones in the aqueous extract of Cassiae semen cause liver injury in rats through lipid metabolism disorder.
Phytomedicine : international journal of phytotherapy and phytopharmacologyDi (2-ethylhexyl) phthalate Disorders Lipid Metabolism via TYK2/STAT1 and Autophagy in Rats.
Biomedical and environmental sciences : BESHematopoietic stem cell transplant does not prevent neurological deterioration in infants with Farber disease: Case report and literature review.
JIMD reportsWhy systematic literature reviews in Fabry disease should include all published evidence.
European journal of medical geneticsKnockdown expression of MECR, a novel gene of mitochondrial FAS II inhibits growth and colony-formation, promotes apoptosis of hepatocelluar carcinoma cells.
Bioscience trendsCorrelation between Obesity and Lipid Profile in Type 2 Diabetes Mellitus Patients at the Endocrine and Metabolic Polyclinic in General Hospital Pirngadi Medan.
Open access Macedonian journal of medical sciences[Eletroacupuncture improves lipid metabolic disorder by regulating hepatic AMPK/p38 MAPK/RRARγ signaling in rats with high-fat diet-induced insulin resistance].
Zhen ci yan jiu = Acupuncture researchInfluence of total polar compounds on lipid metabolism, oxidative stress and cytotoxicity in HepG2 cells.
Lipids in health and diseaseScreening of common genetic variants in the APOB gene related to familial hypercholesterolemia in a Saudi population: A case-control study.
MedicineSpectrum of mutations of familial hypercholesterolemia in the 22 Arab countries.
AtherosclerosisErchen Decoction Ameliorates Lipid Metabolism by the Regulation of the Protein CAV-1 and the Receptors VLDLR, LDLR, ABCA1, and SRB1 in a High-Fat Diet Rat Model.
Evidence-based complementary and alternative medicine : eCAMSREBP-1 and LXRα pathways mediated Cu-induced hepatic lipid metabolism in zebrafish Danio rerio.
ChemosphereAlterations of the Gut Microbiome Associated With the Treatment of Hyperuricaemia in Male Rats.
Frontiers in microbiologyTherapeutic plasma exchange in secondary prevention of acute pancreatitis in pregnant patient with familial hyperchylomicronemia.
Biomedical papers of the Medical Faculty of the University Palacky, Olomouc, CzechoslovakiaLipid metabolism and carcinogenesis, cancer development.
American journal of cancer researchSuppression of NF-κB activation by PDLIM2 restrains hepatic lipogenesis and inflammation in high fat diet induced mice.
Biochemical and biophysical research communicationsNeutral lipid storage disease with myopathy: Further phenotypic characterization of a rare PNPLA2 variant.
Neuromuscular disorders : NMDSkin Changes Revealing a Disorder of Lipid Metabolism.
Deutsches Arzteblatt internationalOxidative stress and mitochondrial dysfunction mediated Cd-induced hepatic lipid accumulation in zebrafish Danio rerio.
Aquatic toxicology (Amsterdam, Netherlands)The brain lipidome in neurodegenerative lysosomal storage disorders.
Biochemical and biophysical research communicationsFamilial Hypercholesterolemia: Cascade Screening in Children and Relatives of the Affected.
Indian journal of pediatrics[Effect of Eletroacupuncture Intervention on Insulin Resistance, Lipid Metabolic Disorder and Expression of Hepatic SREBP-1 c and Fatty Acid Synthase Proteins in Rats with Hyperlipidemia].
Zhen ci yan jiu = Acupuncture researchAnalysis of publicly available LDLR, APOB, and PCSK9 variants associated with familial hypercholesterolemia: application of ACMG guidelines and implications for familial hypercholesterolemia diagnosis.
Genetics in medicine : official journal of the American College of Medical GeneticsAberrant Lipid Metabolism in Hepatocellular Carcinoma Revealed by Liver Lipidomics.
International journal of molecular sciencesDetection and management of familial hypercholesterolaemia in primary care in Australia: protocol for a pragmatic cluster intervention study with pre-post intervention comparisons.
BMJ openPDGFRA, HSD17B4 and HMGB2 are potential therapeutic targets in polycystic ovarian syndrome and breast cancer.
OncotargetFamilial Hypercholesterolemia: A Systematic Review of Guidelines on Genetic Testing and Patient Management.
Frontiers in public healthAssociation of General and Abdominal Obesity With Hypertension, Dyslipidemia and Prediabetes in the PREDAPS Study.
Revista espanola de cardiologia (English ed.)Preventive effect of L-carnitine on the disorder of lipid metabolism and circadian clock of mice subjected to chronic jet-lag.
Physiological researchLight Chain Myeloma induced Severe Hypertriglyceridemia.
Journal of clinical and diagnostic research : JCDRMuscle MRI in neutral lipid storage disease (NLSD).
Journal of neurologyNovel protein biomarkers associated with coronary artery disease in statin-treated patients with familial hypercholesterolemia.
Journal of clinical lipidologyRNA sequence analysis of rat acute experimental pancreatitis with and without fatty liver: a gene expression profiling comparative study.
Scientific reportsA case of sitosterolemia due to compound heterozygous mutations in ABCG5: clinical features and treatment outcomes obtained with colestimide and ezetimibe.
Clinical pediatric endocrinology : case reports and clinical investigations : official journal of the Japanese Society for Pediatric Endocrinology[Hyperlipoproteinemia and dyslipidemia as rare diseases. Diagnostics and treatment].
Vnitrni lekarstviMyocardial layer-specific analysis in patients with heterozygous familial hypercholesterolemia using speckle tracking echocardiography.
Echocardiography (Mount Kisco, N.Y.)Familial defective apolipoprotein B-100: A review.
Journal of clinical lipidologySpectrum of mutations in homozygous familial hypercholesterolemia in India, with four novel mutations.
AtherosclerosisBaicalein protects against oxLDL-caused oxidative stress and inflammation by modulation of AMPK-alpha.
OncotargetCoexistence of VHL Disease and CPT2 Deficiency: A Case Report.
Cancer research and treatmentDiagnosis and treatment of familial hypercholesterolemia: The impact of recent guidelines.
The Nurse practitioner[Study on the prevalence of lipid metabolism disorders and quantitative analysis of apolipoproteins in T2DM patients].
Wei sheng yan jiu = Journal of hygiene research[An Analysis on the Association between Lipid Metabolism and Low Birth Body Mass and Relative Factors among Rural and Urban Adolescents].
Zhongguo yi xue ke xue yuan xue bao. Acta Academiae Medicinae SinicaeLongitudinal assessment of reflexive and volitional saccades in Niemann-Pick Type C disease during treatment with miglustat.
Orphanet journal of rare diseases[Experimental study on intervention effect of Grifola frondosa on nonalcoholic steatohepatitis].
Zhongguo Zhong yao za zhi = Zhongguo zhongyao zazhi = China journal of Chinese materia medicaHomozygous Familial Hypercholesterolemia Associated with Symmetric Subcutaneous Lipomatosis.
Indian journal of dermatologyMolecular-genetic aspects of familial hypercholesterolemia.
Endocrine regulationsEffect of apolipoprotein A1 genetic polymorphisms on lipid profiles and the risk of coronary artery disease.
Diagnostic pathologySodium tanshinone IIA sulfonate ameliorates ischemia-induced myocardial inflammation and lipid accumulation in Beagle dogs through NLRP3 inflammasome.
International journal of cardiologyMutational analysis of a cohort with clinical diagnosis of familial hypercholesterolemia: considerations for genetic diagnosis improvement.
Genetics in medicine : official journal of the American College of Medical GeneticsAssociation between nonalcoholic fatty liver disease and colorectal adenoma: a systematic review and meta-analysis.
International journal of clinical and experimental medicineFamilial Hypercholesterolemia: a Review of the Natural History, Diagnosis, and Management.
Cardiology and therapyModulation of colon cancer by nutmeg.
Journal of proteome researchResveratrol restores the circadian rhythmic disorder of lipid metabolism induced by high-fat diet in mice.
Biochemical and biophysical research communicationsAssociações
Organizações que acompanham esta doença — pra ter apoio e orientação
Ainda não temos associações cadastradas para Alteração do metabolismo lipídico.
É de uma associação que acompanha esta doença? Fale com a gente →
Doença com base genética
Um médico geneticista pode ajudar no diagnóstico de Alteração do metabolismo lipídico e no aconselhamento genético da família.
Doenças relacionadas
Doenças com sintomas parecidos — ajudam quem ainda está buscando diagnóstico
Perguntas frequentes
O que as famílias mais perguntam sobre esta doença — cada resposta com a fonte de onde saiu
Ela é causada por alterações genéticas que resultam na deficiência de enzimas do metabolismo celular. Com isso, as células não conseguem processar e queimar gorduras para a produção de energia necessária.
Referências
Fontes citadas no texto, publicações do grafo e bases de dados usadas neste verbete
7 publicações do grafo RarasNet (PubMed) · 7 bases de dados. Títulos, periódicos e PMIDs vêm direto da fonte, sem intermediação de IA.
Dados compilados pelo RarasNet a partir de fontes abertas (Orphanet, OMIM, MONDO, PubMed/EuropePMC, ClinicalTrials.gov, DATASUS, PCDT/MS). Este conteúdo é informativo e não substitui avaliação médica.
Citar este verbete
Raras. (s.d.). Alteração do metabolismo lipídico. Em Raras — Enciclopédia de Doenças Raras do Brasil. https://raras.org/doenca/alteracao-do-metabolismo-lipidico
Formato APA. Conteúdo sob CC BY 4.0 — reuso livre com atribuição.
Conteúdo mantido por Agente Raras · Médicos e pesquisadores podem colaborar

Alteração do metabolismo lipídico
📋 Origem dos dados
Esta página agrega dados de fontes públicas e oficiais. Dados sobre cobertura no SUS (PCDT, CEAF) são verificados ativamente por agente proativo (ver badge no infobox). Demais dados têm atribuição de fonte + data da última sincronização — clique para abrir o original.
- Doença rara (ontologia)
- fonte: Orphanet
- Identificador unificado
- fonte: MONDO
- Codificação WHO/SUS
- fonte: WHO ICD-10 / DATASUS
- NIH/GARD
- fonte: GARD (NIH)
- Indexação biomédica
- fonte: MeSH (NLM)
- Dado público estruturado
- fonte: Wikidata
- Moléculas estudadas na doença
- fonte: OpenTargets
- Ensaios clínicos
- fonte: ClinicalTrials.gov